Moreover, the KDM5B-NTT isoform is present in breast cancer cells and the TFAP2C-Myc-KDM5B complex is associated with the repression of p21, tumorigenesis, and therapeutic failure. This evidence concerns the gene KDM5B and breast carcinoma.